ArticleAbdominal radiology (New York)2026
Integrated multi-task learning framework for hepatocellular carcinoma segmentation and histological grading using fused multi-phase MRI.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From black-box prediction to transparent insight: the status quo and paradigm shift of explainable artificial intelligence in hepatocellular carcinoma research.Journal of the Egyptian National Cancer Institute · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to develop and validate an integrated multi-task framework for hepatocellular carcinoma analysis by combining deep learning-based segmentation with radiomics-based histological grading using fused multi-phase MRI. MATERIALS AND
methodsIn this retrospective study, MRI data from 1673 patients with histopathologically confirmed hepatocellular carcinoma (875 high-grade, 798 low-grade) were analyzed. Arterial-phase and portal-venous-phase T1-weighted images were acquired using a standardized, bolus-tracking protocol to ensure consistent contrast timing. Six segmentation models, Vision Transformer, nnU-Net, U-Net, DeepLabV3+, Swin Transformer, and SegNet, were trained on arterial, portal-venous, and fused (wavelet-based) MRI data. Radiomic features (n = 215) were extracted from segmented tumor volumes and pre-filtered to remove multicollinearity. Feature refinement was performed using Lasso, Recursive Feature Elimination (RFE), and ANOVA. Tumor grade classification was conducted using TabTransformer, TabNet, XGBoost, and CatBoost. Five-fold cross-validation and an independent test set were used for robust evaluation. Standardized preprocessing, including intensity normalization, bias field correction, and inter-phase registration, ensured consistent image quality and analytical reproducibility.
resultsThe proposed framework achieved high segmentation accuracy with DSC scores above 0.92 across fused MRI images. Classification performance was exceptional, with training accuracy reaching 93.2% and testing accuracy 92.5%, while AUC values exceeded 96% in the fused modality. Comparative analyses revealed that the Transformer-RFE-Fused model outperformed alternative architectures, demonstrating superior generalization and robust feature learning. In addition, SHAP analysis confirmed the high contribution of key radiomic features, and t-SNE visualizations illustrated clear separation between low-grade and high-grade tumors. These results validate the efficacy of our multi-task learning approach in enhancing HCC tumor segmentation and grading. Our evaluation underscores the clinical potential of our integrated framework for accurate, reproducible, and interpretable HCC diagnosis.
conclusionsOur integrated multi-task learning framework markedly improves HCC tumor segmentation and grading. Transformer-RFE-Fused (Wavelet) MRI offers superior accuracy and robustness, efficiently paving the way for enhanced clinical decision-making.
Indexed as
Identifiers
41160193What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.